Google DeepMind (and Google Research)
Google DeepMind built AlphaFold, AlphaMissense, AlphaGenome and Med-Gemini, the reference models for structure, variants, and medical multimodal reasoning.
AlphaFold 2 (2020) and AlphaFold 3 (2024) redefined structure prediction; Isomorphic Labs commercialises drug discovery on top. AlphaMissense (2023) scored every possible human missense variant; AlphaGenome (preview June 2025, Nature January 2026) predicts regulatory effects across 1 Mb of sequence. Google Research's Med-Gemini and C2S-Scale extend into clinical and single-cell domains.
Pages like this
not linked directly; found by shared links- InstitutionYale School of Medicine / Yale Cancer Center
Shares Cell2Sentence / C2S-Scale (Yale, Google), Virtual cell roadmap: from bulk omics to a predictive model of a cancer cell and the tag ai.
- CompanyVevo Therapeutics
Shares Virtual cell roadmap: from bulk omics to a predictive model of a cancer cell and the tag ai.
- CompanyChan Zuckerberg Initiative (Biohub)
Shares Virtual cell roadmap: from bulk omics to a predictive model of a cancer cell and the tag ai.
- InstitutionArc Institute
Shares Virtual cell roadmap: from bulk omics to a predictive model of a cancer cell and the tag ai.